NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Up 80.4% in February

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 19,795 shares, an increase of 80.4% from the February 12th total of 10,974 shares. Currently, 3.0% of the company’s stock are short sold. Based on an average daily volume of 71,938 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 71,938 shares, the short-interest ratio is presently 0.3 days. Currently, 3.0% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, December 6th. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a report on Wednesday, January 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

NewGenIvf Group Stock Performance

Shares of NewGenIvf Group stock opened at $0.50 on Friday. The company has a current ratio of 3.43, a quick ratio of 3.37 and a debt-to-equity ratio of 0.17. NewGenIvf Group has a 12-month low of $0.48 and a 12-month high of $1,110.00. The business’s 50 day moving average is $1.16 and its 200-day moving average is $10.81.

NewGenIvf Group’s stock is set to reverse split on the morning of Monday, March 16th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, March 15th.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.